Concepedia

Stephen D. Wiviott

SD

Statistics

Publications

55

Citations

5K

H-Index

35

Active since

1996

Affiliations

Brigham and Women's Hospital(Current)

Thrombolysis in Myocardial Infarction Study Group

Harvard University

The University of Texas Southwestern Medical Center

St. Michael's Hospital

Stephen D. Wiviott is an author at Brigham and Women's Hospital specializing in medicine, cardiovascular pharmacotherapy, and cardiology.

ORCID

Publications per year

1996–2025

55

Publications

55

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn et al. · The Lancet Diabetes & Endocrinology · 2019 · 675 citations · Full text

, , +14

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

Steven Grinspoon, Kathleen V. Fitch, Markella V. Zanni et al. · New England Journal of Medicine · 2023 · 455 citations · Full text

, , +10

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus

Thomas A. Zelniker, Marc P. Bonaca, Remo H.M. Furtado et al. · Circulation · 2020 · 452 citations · Full text

, , +17

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease

Michelle L. O’Donoghue, Robert P. Giugliano, Stephen D. Wiviott et al. · Circulation · 2022 · 380 citations · Full text

, , +17

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction

Remo H.M. Furtado, Marc P. Bonaca, Itamar Raz et al. · Circulation · 2019 · 330 citations

, , +17

1–5 of 55